Document is current
Any future updates will be listed below
-
Authors
Bifani, Amanda Makha
Choy, Milly M.
Tan, Hwee Cheng
Ooi, Eng Eong https://orcid.org/0000-0002-0520-1544
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (MOH-000135-00, MOH-000135-00, MOH-000135-00, MOH-000135-00)
- License Information
-
More Information
Article History
Received: 4 January 2021
Accepted: 31 March 2021
First Online: 20 May 2021
Competing interests
: E.E.O. served as a dengue vaccine advisory board member for Takeda Vaccines, which uses the DENV2 PDK53 strain as a component of their dengue vaccine candidate. All other authors declare that there are no competing interests.
